| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | ciliary pocket membrane | 3.31e-05 | 3 | 70 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 3.31e-05 | 3 | 70 | 2 | GO:0020016 | |
| Domain | EHD_N | 4.80e-07 | 5 | 69 | 3 | IPR031692 | |
| Domain | EHD_N | 4.80e-07 | 5 | 69 | 3 | PF16880 | |
| Domain | Spectrin_repeat | 3.78e-06 | 29 | 69 | 4 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 5.67e-06 | 32 | 69 | 4 | IPR018159 | |
| Domain | SPEC | 5.67e-06 | 32 | 69 | 4 | SM00150 | |
| Domain | EF-hand_4 | 5.68e-06 | 10 | 69 | 3 | PF12763 | |
| Domain | EH | 7.80e-06 | 11 | 69 | 3 | PS50031 | |
| Domain | EH | 7.80e-06 | 11 | 69 | 3 | SM00027 | |
| Domain | EH_dom | 7.80e-06 | 11 | 69 | 3 | IPR000261 | |
| Domain | EHD1/EHD3 | 1.35e-05 | 2 | 69 | 2 | IPR029951 | |
| Domain | G_DYNAMIN_dom | 1.71e-05 | 14 | 69 | 3 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 1.71e-05 | 14 | 69 | 3 | PS51718 | |
| Domain | Dynamin_GTPase | 2.13e-05 | 15 | 69 | 3 | IPR001401 | |
| Domain | Dynamin_N | 2.13e-05 | 15 | 69 | 3 | PF00350 | |
| Domain | Dynamin_SF | 2.13e-05 | 15 | 69 | 3 | IPR022812 | |
| Domain | Spectrin | 8.11e-05 | 23 | 69 | 3 | PF00435 | |
| Domain | EF-hand_Ca_insen | 2.00e-04 | 6 | 69 | 2 | IPR014837 | |
| Domain | EFhand_Ca_insen | 2.00e-04 | 6 | 69 | 2 | PF08726 | |
| Domain | DHC_N1 | 3.71e-04 | 8 | 69 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 3.71e-04 | 8 | 69 | 2 | IPR013594 | |
| Domain | - | 3.92e-04 | 746 | 69 | 10 | 3.40.50.300 | |
| Domain | - | 4.04e-04 | 261 | 69 | 6 | 1.10.238.10 | |
| Domain | EF_Hand_1_Ca_BS | 4.72e-04 | 175 | 69 | 5 | IPR018247 | |
| Domain | EF-hand-dom_pair | 6.65e-04 | 287 | 69 | 6 | IPR011992 | |
| Domain | aa-tRNA-synt_IIb | 7.24e-04 | 11 | 69 | 2 | IPR002314 | |
| Domain | tRNA-synt_2b | 7.24e-04 | 11 | 69 | 2 | PF00587 | |
| Domain | - | 7.24e-04 | 11 | 69 | 2 | 3.40.50.800 | |
| Domain | EF_HAND_1 | 9.44e-04 | 204 | 69 | 5 | PS00018 | |
| Domain | START | 1.02e-03 | 13 | 69 | 2 | SM00234 | |
| Domain | P-loop_NTPase | 1.06e-03 | 848 | 69 | 10 | IPR027417 | |
| Domain | Dynein_heavy_chain_D4_dom | 1.19e-03 | 14 | 69 | 2 | IPR024317 | |
| Domain | Dynein_HC_stalk | 1.19e-03 | 14 | 69 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 1.19e-03 | 14 | 69 | 2 | IPR013602 | |
| Domain | DHC_N2 | 1.19e-03 | 14 | 69 | 2 | PF08393 | |
| Domain | MT | 1.19e-03 | 14 | 69 | 2 | PF12777 | |
| Domain | AAA_8 | 1.19e-03 | 14 | 69 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 1.19e-03 | 14 | 69 | 2 | IPR011704 | |
| Domain | Anticodon-bd | 1.19e-03 | 14 | 69 | 2 | IPR004154 | |
| Domain | AAA_5 | 1.19e-03 | 14 | 69 | 2 | PF07728 | |
| Domain | DHC_fam | 1.37e-03 | 15 | 69 | 2 | IPR026983 | |
| Domain | START | 1.37e-03 | 15 | 69 | 2 | PF01852 | |
| Domain | START_lipid-bd_dom | 1.37e-03 | 15 | 69 | 2 | IPR002913 | |
| Domain | Dynein_heavy_dom | 1.37e-03 | 15 | 69 | 2 | IPR004273 | |
| Domain | START | 1.37e-03 | 15 | 69 | 2 | PS50848 | |
| Domain | Dynein_heavy | 1.37e-03 | 15 | 69 | 2 | PF03028 | |
| Domain | EF_HAND_2 | 1.64e-03 | 231 | 69 | 5 | PS50222 | |
| Domain | EF_hand_dom | 1.67e-03 | 232 | 69 | 5 | IPR002048 | |
| Domain | aa-tRNA-synth_II | 1.98e-03 | 18 | 69 | 2 | IPR006195 | |
| Domain | AA_TRNA_LIGASE_II | 1.98e-03 | 18 | 69 | 2 | PS50862 | |
| Domain | EF-hand_1 | 2.42e-03 | 152 | 69 | 4 | PF00036 | |
| Domain | SH3_9 | 3.01e-03 | 78 | 69 | 3 | PF14604 | |
| Domain | - | 3.24e-03 | 23 | 69 | 2 | 3.30.530.20 | |
| Domain | START-like_dom | 3.24e-03 | 23 | 69 | 2 | IPR023393 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 4.39e-06 | 9 | 54 | 3 | MM15487 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 1.14e-05 | 12 | 54 | 3 | M27738 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 1.43e-04 | 5 | 54 | 2 | M26920 | |
| Pubmed | TTF2 BPTF WDR33 SPTAN1 SH3D19 CCDC85C CHD8 ACTN1 PRPF40A DYNC1H1 STAT3 | 1.28e-08 | 549 | 70 | 11 | 38280479 | |
| Pubmed | C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH? | 3.12e-08 | 4 | 70 | 3 | 16155252 | |
| Pubmed | Rabenosyn-5 and EHD1 interact and sequentially regulate protein recycling to the plasma membrane. | 3.12e-08 | 4 | 70 | 3 | 15020713 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 17233914 | ||
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 10673336 | ||
| Pubmed | EH domain proteins regulate cardiac membrane protein targeting. | 7.79e-08 | 5 | 70 | 3 | 20489164 | |
| Pubmed | DDX31 SYNE3 STXBP3 PIEZO1 SPTAN1 MTR VARS2 EBNA1BP2 MAP7 NCLN TARS2 HSPA12B DNAJC3 TOP3B PRPF40A | 2.14e-07 | 1487 | 70 | 15 | 33957083 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TTF2 CLASP1 WDR33 SPTAN1 EHD1 CHD8 EBNA1BP2 MAP7 PRPF40A DYNC1H1 | 2.57e-07 | 582 | 70 | 10 | 20467437 |
| Pubmed | SYNE3 CLASP1 NBEAL2 EHD1 MAP3K11 RNF213 EIF3D NCLN FUT7 DNAJC3 G6PD PRPF40A DYNC1H1 | 5.19e-07 | 1168 | 70 | 13 | 19946888 | |
| Pubmed | The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. | 1.27e-06 | 11 | 70 | 3 | 26455409 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TNRC18 LRFN1 SYNE3 NBEAL2 PIEZO1 SREBF1 MAP3K11 CHD8 PKN1 NCLN TOP3B DYNC1H1 | 1.94e-06 | 1105 | 70 | 12 | 35748872 |
| Pubmed | NEFH LRFN1 CLASP1 SPTAN1 SH3D19 PRKCA CHD8 PKN1 TOP3B DYNC1H1 EHD3 | 3.37e-06 | 963 | 70 | 11 | 28671696 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 11802708 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17525530 | ||
| Pubmed | SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment. | 3.99e-06 | 2 | 70 | 2 | 26226295 | |
| Pubmed | VARS2 and TARS2 mutations in patients with mitochondrial encephalomyopathies. | 3.99e-06 | 2 | 70 | 2 | 24827421 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 29471502 | ||
| Pubmed | The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis. | 3.99e-06 | 2 | 70 | 2 | 32638182 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26250461 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23693134 | ||
| Pubmed | BPTF DDX31 WDR33 SPTAN1 MTR CCDC85C CHD8 EIF3D EBNA1BP2 MAP7 PRPF40A DYNC1H1 STAT3 | 4.82e-06 | 1429 | 70 | 13 | 35140242 | |
| Pubmed | 6.44e-06 | 653 | 70 | 9 | 22586326 | ||
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | 8.16e-06 | 235 | 70 | 6 | 28378594 | |
| Pubmed | PKN associates and phosphorylates the head-rod domain of neurofilament protein. | 1.20e-05 | 3 | 70 | 2 | 8621664 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 33872798 | ||
| Pubmed | Synaptic adhesion-like molecules (SALMs) promote neurite outgrowth. | 1.20e-05 | 3 | 70 | 2 | 18585462 | |
| Pubmed | Protein kinase C regulates rod photoreceptor differentiation through modulation of STAT3 signaling. | 1.20e-05 | 3 | 70 | 2 | 20237998 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 21177873 | ||
| Pubmed | Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation. | 1.20e-05 | 3 | 70 | 2 | 25686250 | |
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 19913854 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 9030526 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 37356345 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 28943089 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 34421818 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 24019528 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 12121420 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 34411567 | ||
| Pubmed | 1.20e-05 | 3 | 70 | 2 | 28745314 | ||
| Pubmed | 1.27e-05 | 538 | 70 | 8 | 28524877 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | STARD13 TTF2 GTF2H4 SPTAN1 EHD1 PRKCA CHD8 ACTN1 EIF3D EBNA1BP2 G6PD DYNC1H1 | 1.51e-05 | 1353 | 70 | 12 | 29467282 |
| Pubmed | 1.92e-05 | 78 | 70 | 4 | 17192257 | ||
| Pubmed | Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early endosomal transport. | 2.39e-05 | 4 | 70 | 2 | 16251358 | |
| Pubmed | Btn2a2 Regulates ILC2-T Cell Cross Talk in Type 2 Immune Responses. | 2.39e-05 | 4 | 70 | 2 | 35145516 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 18812467 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 27189942 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 15576373 | ||
| Pubmed | Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. | 2.39e-05 | 4 | 70 | 2 | 29212907 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 11930178 | ||
| Pubmed | PRK1 phosphorylates MARCKS at the PKC sites: serine 152, serine 156 and serine 163. | 2.39e-05 | 4 | 70 | 2 | 8557118 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 20554776 | ||
| Pubmed | Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes. | 2.39e-05 | 4 | 70 | 2 | 26809444 | |
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 15930129 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 25329545 | ||
| Pubmed | 2.39e-05 | 4 | 70 | 2 | 23589618 | ||
| Pubmed | 2.47e-05 | 28 | 70 | 3 | 26884322 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | GTF2H4 CLASP1 WDR33 SREBF1 CCDC85C CHD8 ACTN1 EBNA1BP2 NCLN PRPF40A STAT3 | 2.70e-05 | 1203 | 70 | 11 | 29180619 |
| Pubmed | SPTAN1 EHD1 PRKCA RNF213 EIF3D EBNA1BP2 MAP7 NCLN G6PD DYNC1H1 STAT3 EHD2 | 2.79e-05 | 1440 | 70 | 12 | 30833792 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 3.50e-05 | 183 | 70 | 5 | 31932471 | |
| Pubmed | 3.88e-05 | 187 | 70 | 5 | 26460568 | ||
| Pubmed | NSD3-Short Is an Adaptor Protein that Couples BRD4 to the CHD8 Chromatin Remodeler. | 3.98e-05 | 5 | 70 | 2 | 26626481 | |
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 18395093 | ||
| Pubmed | 3.98e-05 | 5 | 70 | 2 | 21115825 | ||
| Pubmed | DDX31 STXBP3 SPTAN1 CCDC85C RNF213 EIF2AK4 TARS2 G6PD TOP3B MTMR9 | 4.59e-05 | 1049 | 70 | 10 | 27880917 | |
| Pubmed | 5.67e-05 | 332 | 70 | 6 | 37433992 | ||
| Pubmed | MICAL-L1 links EHD1 to tubular recycling endosomes and regulates receptor recycling. | 5.96e-05 | 6 | 70 | 2 | 19864458 | |
| Pubmed | Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. | 5.96e-05 | 6 | 70 | 2 | 20228790 | |
| Pubmed | A NUDEL-dependent mechanism of neurofilament assembly regulates the integrity of CNS neurons. | 5.96e-05 | 6 | 70 | 2 | 15208636 | |
| Pubmed | BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation. | 5.96e-05 | 6 | 70 | 2 | 20208008 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 6.44e-05 | 208 | 70 | 5 | 33230847 | |
| Pubmed | 8.33e-05 | 7 | 70 | 2 | 16828986 | ||
| Pubmed | Requirement for math5 in the development of retinal ganglion cells. | 8.33e-05 | 7 | 70 | 2 | 11156601 | |
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 8.33e-05 | 7 | 70 | 2 | 11170752 | |
| Pubmed | Brain spectrin binding to the NMDA receptor is regulated by phosphorylation, calcium and calmodulin. | 8.33e-05 | 7 | 70 | 2 | 9670010 | |
| Pubmed | A novel family of adhesion-like molecules that interacts with the NMDA receptor. | 8.33e-05 | 7 | 70 | 2 | 16495444 | |
| Pubmed | DDX31 CLASP1 WDR33 SPTAN1 EHD1 EIF2AK4 VARS2 EBNA1BP2 PRPF40A DYNC1H1 STAT3 | 8.77e-05 | 1371 | 70 | 11 | 36244648 | |
| Pubmed | 8.86e-05 | 360 | 70 | 6 | 33111431 | ||
| Pubmed | 1.11e-04 | 8 | 70 | 2 | 15247266 | ||
| Pubmed | M phase-specific association of human topoisomerase IIIbeta with chromosomes. | 1.11e-04 | 8 | 70 | 2 | 11549288 | |
| Pubmed | Myosin Vb interacts with Rab8a on a tubular network containing EHD1 and EHD3. | 1.11e-04 | 8 | 70 | 2 | 17507647 | |
| Pubmed | mTORC1 accelerates retinal development via the immunoproteasome. | 1.11e-04 | 46 | 70 | 3 | 29950673 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | STXBP3 SPTAN1 MTR EIF3D EBNA1BP2 NCLN TARS2 DNAH5 G6PD PRPF40A DYNC1H1 | 1.23e-04 | 1425 | 70 | 11 | 30948266 |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | 1.36e-04 | 754 | 70 | 8 | 33060197 | |
| Pubmed | STARD13 BPTF TNRC18 WDR33 SPTAN1 EIF2AK4 ACTN1 EBNA1BP2 DNAJC3 TOP3B PPL | 1.37e-04 | 1442 | 70 | 11 | 35575683 | |
| Pubmed | 1.42e-04 | 9 | 70 | 2 | 10194441 | ||
| Pubmed | Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. | 1.42e-04 | 9 | 70 | 2 | 11423532 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | STARD13 FASTKD1 RNF213 CHD8 VARS2 NCLN TARS2 DNAJC3 G6PD PRPF40A EHD2 | 1.44e-04 | 1451 | 70 | 11 | 30550785 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | TTF2 WDR33 SH3D19 FASTKD1 MTR RNF213 VARS2 EBNA1BP2 NCLN TARS2 TOP3B | 1.88e-04 | 1496 | 70 | 11 | 32877691 |
| Pubmed | 1.93e-04 | 263 | 70 | 5 | 12665801 | ||
| Pubmed | 1.97e-04 | 417 | 70 | 6 | 19199708 | ||
| Pubmed | 1.98e-04 | 142 | 70 | 4 | 30809309 | ||
| Pubmed | 2.09e-04 | 144 | 70 | 4 | 35681168 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.15e-04 | 807 | 70 | 8 | 22681889 | |
| Pubmed | Brain proteins interacting with the tetramerization region of non-erythroid alpha spectrin. | 2.17e-04 | 11 | 70 | 2 | 17607528 | |
| Pubmed | 2.17e-04 | 11 | 70 | 2 | 11104762 | ||
| Pubmed | Genetic predictors of medically refractory ulcerative colitis. | 2.17e-04 | 11 | 70 | 2 | 20848476 | |
| Pubmed | BPTF SPTAN1 EBNA1BP2 MAP7 NCLN DNAJC3 G6PD TOP3B DYNC1H1 STAT3 | 2.61e-04 | 1297 | 70 | 10 | 33545068 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.71e-04 | 1061 | 70 | 9 | 33845483 | |
| Pubmed | 2.84e-04 | 63 | 70 | 3 | 37052853 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | STARD13 LRFN1 CLASP1 CCDC85C ACTN1 EIF3D MAP7 NCLN DYNC1H1 EHD3 | 3.02e-04 | 1321 | 70 | 10 | 27173435 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | 3.13e-04 | 853 | 70 | 8 | 28718761 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q34 | 1.57e-03 | 325 | 70 | 4 | chr9q34 | |
| GeneFamily | C2 domain containing protein kinases | 3.06e-04 | 10 | 48 | 2 | 835 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 7.09e-04 | 15 | 48 | 2 | 458 | |
| GeneFamily | StAR related lipid transfer domain containing | 7.09e-04 | 15 | 48 | 2 | 759 | |
| GeneFamily | EF-hand domain containing | 2.69e-03 | 219 | 48 | 4 | 863 | |
| Coexpression | TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP | 1.74e-05 | 203 | 70 | 6 | M10184 | |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN | 2.15e-05 | 125 | 70 | 5 | M19629 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-05 | 187 | 70 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.33e-05 | 193 | 70 | 5 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 197 | 70 | 5 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-05 | 197 | 70 | 5 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-I_(AT1)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.54e-05 | 199 | 70 | 5 | 5a002d49a8b84c158f7b4d7a3e78e6a937757bb7 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.54e-05 | 199 | 70 | 5 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | be55cef682ba87250dad97689332c8820b3a7420 | |
| Drug | dicaprylphosphatidylcholine | 1.54e-06 | 8 | 70 | 3 | CID000166886 | |
| Drug | Khellin [82-02-0]; Down 200; 15.4uM; HL60; HG-U133A | 2.31e-06 | 195 | 70 | 7 | 2004_DN | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; HL60; HG-U133A | 2.47e-06 | 197 | 70 | 7 | 1394_UP | |
| Drug | TIBA | 5.01e-06 | 37 | 70 | 4 | CID000006948 | |
| Drug | Starch | 3.06e-05 | 20 | 70 | 3 | ctd:D013213 | |
| Drug | Condelphine [7633-69-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 6357_DN | |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; PC3; HT_HG-U133A | 3.13e-05 | 196 | 70 | 6 | 3985_DN | |
| Drug | Berberine chloride [633-65-8]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6791_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; HL60; HG-U133A | 3.31e-05 | 198 | 70 | 6 | 1999_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 70 | 6 | 6271_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.40e-05 | 199 | 70 | 6 | 1055_DN | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 3.40e-05 | 199 | 70 | 6 | 6963_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; HL60; HG-U133A | 3.50e-05 | 200 | 70 | 6 | 1994_DN | |
| Drug | Haloperidol [52-86-8]; Down 200; 10.6uM; HL60; HG-U133A | 3.50e-05 | 200 | 70 | 6 | 2039_DN | |
| Drug | sodium taurodihydrofusidate | 5.57e-05 | 4 | 70 | 2 | CID003035005 | |
| Disease | phenylketonuria (biomarker_via_orthology) | 1.48e-05 | 3 | 66 | 2 | DOID:9281 (biomarker_via_orthology) | |
| Disease | gonadal dysgenesis (implicated_via_orthology) | 2.95e-05 | 4 | 66 | 2 | DOID:14447 (implicated_via_orthology) | |
| Disease | post-traumatic stress disorder | 9.11e-05 | 202 | 66 | 5 | EFO_0001358 | |
| Disease | Gastrointestinal Diseases | 3.21e-04 | 12 | 66 | 2 | C0017178 | |
| Disease | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 3.21e-04 | 12 | 66 | 2 | C0023485 | |
| Disease | Functional Gastrointestinal Disorders | 3.21e-04 | 12 | 66 | 2 | C0559031 | |
| Disease | Cholera Infantum | 3.21e-04 | 12 | 66 | 2 | C1565321 | |
| Disease | prostate carcinoma (is_implicated_in) | 3.78e-04 | 13 | 66 | 2 | DOID:10286 (is_implicated_in) | |
| Disease | response to irinotecan | 5.08e-04 | 15 | 66 | 2 | EFO_0004829 | |
| Disease | Autism Spectrum Disorders | 9.26e-04 | 85 | 66 | 3 | C1510586 | |
| Disease | kidney disease (biomarker_via_orthology) | 1.01e-03 | 21 | 66 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.00e-03 | 111 | 66 | 3 | EFO_0004530, EFO_0008595 | |
| Disease | endometrial carcinoma | 2.10e-03 | 113 | 66 | 3 | EFO_1001512 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELREIEWRCVIIDEA | 936 | Q9HCK8 | |
| WLLNEIRRLERLDHL | 381 | P12814 | |
| DTVRLWRLFREILDG | 821 | Q9P2K8 | |
| RWFAERVDLIILLFD | 176 | Q9NZN4 | |
| LEVLERAKRRAVDWH | 26 | Q9NQ31 | |
| LWDEEDFQGRRCRLL | 16 | P53672 | |
| EELELWEIRAFAERV | 2016 | Q12830 | |
| LEVCVWDAELRELRA | 181 | Q13217 | |
| AQRLEERERIIREIW | 121 | Q9H8M9 | |
| HFVRSDELREAWRIF | 451 | P11413 | |
| DVLAWEHERFAIRRL | 366 | Q969V3 | |
| AWEIRDRLLAERVCD | 111 | Q02548 | |
| LELEAWERGRAVDLR | 311 | P43026 | |
| LAAREIVWLEREERA | 81 | Q14244 | |
| RTIRGFEALIEREWL | 356 | Q96QG7 | |
| LWLRRLTREDDLETC | 261 | Q9P244 | |
| EELLRWSKEELARRL | 21 | A6NKD9 | |
| CLAEFKRDLEWVERL | 56 | Q99848 | |
| VWSAVDIRDRQRLLE | 616 | Q16549 | |
| RLWSLERELDDLKRL | 1611 | O60437 | |
| RVRLFTDWRERFCAI | 306 | Q11130 | |
| ELVWLRRLAREDDLE | 256 | Q9BTN0 | |
| RLRWLVFDEADRILD | 381 | Q9H8H2 | |
| LLVRDGRRWCTDVFE | 561 | Q96MM6 | |
| IELDAVWEDIRERFV | 761 | O75400 | |
| TLQSEEWFRVRLDRL | 286 | P12036 | |
| LWVEERFTAHIARVR | 826 | O14638 | |
| RRWKLGDDIDLIVRC | 361 | O15371 | |
| VEALVTEAWRRLERF | 136 | Q53R41 | |
| TEAWRRLERFDIKLL | 141 | Q53R41 | |
| EELRWRRTFLHAVDV | 316 | Q7KYR7 | |
| RVVEHWIEVARECRI | 461 | Q12967 | |
| LIRIWAHEALRLFQD | 2821 | Q14204 | |
| ELRWRRTFLHAADVV | 316 | Q8WVV5 | |
| EWFAERVDRIILLFD | 176 | Q9H4M9 | |
| REHLLAQWELEVFER | 441 | Q16584 | |
| LEFEVLFHRAWLRQI | 671 | Q8TE73 | |
| EWISHIEECVRRQLR | 121 | Q96S99 | |
| EAWREEAELRDHRRI | 291 | Q9BW92 | |
| RHELSREAFLREVWQ | 206 | Q5ST30 | |
| ERAVLEEEFRWLLHD | 11 | Q9GZN7 | |
| VLNRVLRERHLWDED | 966 | Q9Y3M8 | |
| LILWEEERAERRLTA | 341 | Q8IYL2 | |
| LVGDCRRVIWRDLEA | 256 | Q9BQS2 | |
| DRIQILERLDSDWCR | 686 | Q5HYK7 | |
| RELAESWRALRLLEE | 731 | Q6ZMZ3 | |
| VREHAFFRRIDWEKL | 591 | P17252 | |
| LCLDLWGTERREERR | 1386 | Q9UFD9 | |
| ELRLFLAQRLRWLCD | 466 | Q6ZNJ1 | |
| AFAEELHERVRRELW | 1136 | Q99707 | |
| LELERARELELAVFW | 421 | Q16512 | |
| ILEEEDDLWVRIRHR | 281 | O00186 | |
| EWFAERVDRIILLFD | 176 | Q9NZN3 | |
| VLHRVLRERALWDED | 876 | Q92502 | |
| WLRRDEEAAERLCPL | 886 | P36956 | |
| EVICEAWLRDLLFAR | 346 | Q9NS84 | |
| RRRCFEFLDLLLQEW | 461 | Q7Z460 | |
| IRLWELERDRLRFTE | 391 | Q92759 | |
| VEEALDWRREELLLL | 1136 | Q63HN8 | |
| LLDWDRVRVFDREIA | 256 | O95985 | |
| DDLWTRRRSERIFLH | 1991 | O15417 | |
| LALWDFLDFIVRTRI | 2831 | Q8N2C7 | |
| IARIVARCLWEESRL | 101 | P40763 | |
| SEERAALLELWELRR | 446 | Q13813 | |
| EAFWGLEALRELRLE | 271 | Q7L0X0 | |
| RERERLHEEWLLREQ | 71 | Q15695 | |
| RDTRARLVLWDCLIL | 1206 | Q92508 | |
| RLWDLRTLRCERHFE | 736 | A2RRH5 | |
| VRIWDFLRCHEERIL | 226 | Q9C0J8 | |
| REALIRLRELCHQWL | 61 | O95125 | |
| LLRIAWARIILDEAH | 726 | Q9UNY4 |